Wilms-Tumor, Nephroblastom | ||
Allgemeines |
||
Epidemiologie |
||
Prognose | ||
Wilms |
Nephroblastom, Wilms-Tumor. WT1: Wilms-Tumor-Gen, Schlüsselrolle bei der Entwicklung der Niere. Fehlfunktion im Kindesalter führt zum Nephroblastom. | |
Genetik |
||
Klinik |
||
Metastasierung |
||
Staging |
NWTS-3-Staging Stage I Tumor confined to the kidney and completely resected; no penetration of the renal capsule or involvement of renal sinus vessels Stage II Tumor extends beyond the kidney but is completely resected (negative margins and lymph nodes); at least one of the following has occurred: Penetration of the renal capsule Invasion of the renal sinus vessels Biopsy of the tumor before removal Spillage of tumor locally during removal Stage III Gross or microscopic residual tumor remains postoperatively including: Positive surgical margins Tumor spill involving peritoneal surface Regional lymph node metastases Transected vena caval tumor thrombus Stage IV Hematogenous metastases or lymph node metastases outside the abdomen Stage V Bilateral renal Wilms tumors | |
Diagnostik |
||
Morphologie |
||
Therapie |
||
Operation |
||
Radiatio |
||
Chemotherapie |
||
Zytokintherapie |
||
Targettherapie |
||
offene Protokolle | ||
Ergebnisse |
||
Quellen |
1.) Mitchell C, Pritchard-Jones K, Shannon R, et al.: Immediate nephrectomy versus preoperative chemotherapy in the management of non-metastatic Wilms’ tumour: Results of a randomised trial (UKW3) by the UK Children’s Cancer Study Group. Eur J Cancer 42(2006):2554–2562 2.) de Kraker J, Graf N, van Tinteren H, et al.: Reduction of postoperative chemotherapy in children with stage I intermediate risk and anaplastic Wilms’ tumour (SIOP 93-01 trial): A randomised controlled trial. Lancet 364(2004):1229–1235. | |
Impressum Zuletzt geändert am 06.06.2022 8:18